ACS Nano · 2019 · 84 citations · 43 references
MedicineNuclear MedicineOncologyMolecular ImagingRadionuclide TherapyTherapeutic Nuclear MedicineNanomedicineRadiopharmaceutical TherapyTargeted Imaging AgentsTargeted Radionuclide TherapyTargeted TherapyTumor ImagingGraft PolymersMolecular Targeting LigandsNanoparticle Imaging AgentsPretargeted ImagingTargeted Radionuclide ImagingTetrazine Ligation LabelingTumor Targeting LigandsTumor-targeted Bioorthogonal Chemistry
In-labeled imaging agent is a 1,2,4,5-tetrazine derivative, which can react with aforementioned TCO-modified PeptoBrushes in a rapid bioorthogonal ligation. A high degree of TCO loading (up to 30%) was achieved, without altering the physicochemical properties of the polymeric nanoparticle. The highest degree of TCO loading resulted in significantly increased reaction rates (77-fold enhancement) compared to those with small molecule TCO moieties when using lipophilic tetrazines. Based on computer simulations, we hypothesize that this increase is a result of hydrophobic effects and significant rearrangements within the polymer framework, in which hydrophobic patches of TCO moieties are formed. These patches attract lipophilic tetrazines, leading to increased reaction rates in the bioorthogonal ligation. The most reactive system was evaluated as a targeting agent for pretargeted imaging in tumor-bearing mice. After the setup was optimized, sufficient tumor-to-background ratios were achieved as early as 2 h after administration of the tetrazine imaging agent, which further improved at 22 h, enabling clear visualization of CT-26 tumors. These findings show the potential of PeptoBrushes to be used as a pretargeting agent when an optimized dose of polymer is used.
43
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations